C.L. Bowden

1.7k total citations · 1 hit paper
31 papers, 1.3k citations indexed

About

C.L. Bowden is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, C.L. Bowden has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 7 papers in Pharmacology and 4 papers in Clinical Psychology. Recurrent topics in C.L. Bowden's work include Bipolar Disorder and Treatment (16 papers), Schizophrenia research and treatment (6 papers) and Treatment of Major Depression (6 papers). C.L. Bowden is often cited by papers focused on Bipolar Disorder and Treatment (16 papers), Schizophrenia research and treatment (6 papers) and Treatment of Major Depression (6 papers). C.L. Bowden collaborates with scholars based in United States, Spain and Switzerland. C.L. Bowden's co-authors include J. P. Hatch, Pablo Najt, Jair C. Soares, Marco Aurélio Monteiro Peluso, Ernest S. Barratt, E. Serap Monkul, Marsal Sanches, David C. Glahn, J.R. Calabrese and A. John Rush and has published in prestigious journals such as JAMA, Blood and American Journal of Psychiatry.

In The Last Decade

C.L. Bowden

30 papers receiving 1.2k citations

Hit Papers

Efficacy of Divalproex vs Lithium and Placebo in the Trea... 1994 2026 2004 2015 1994 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.L. Bowden United States 12 1.0k 373 248 131 79 31 1.3k
Susan L. McElroy United States 14 1.3k 1.3× 356 1.0× 453 1.8× 172 1.3× 26 0.3× 19 1.6k
Melvin D. Shelton United States 14 839 0.8× 216 0.6× 132 0.5× 128 1.0× 15 0.2× 19 930
E. Sherwood Brown United States 10 455 0.4× 166 0.4× 174 0.7× 87 0.7× 25 0.3× 22 779
Christian Simhandl Austria 16 703 0.7× 87 0.2× 206 0.8× 123 0.9× 139 1.8× 33 959
Haranath Parepally United States 16 986 1.0× 112 0.3× 320 1.3× 107 0.8× 67 0.8× 24 1.2k
Randall Owen United States 15 1.2k 1.2× 176 0.5× 362 1.5× 142 1.1× 52 0.7× 29 1.6k
Keith Karcher United States 17 1.2k 1.2× 175 0.5× 264 1.1× 214 1.6× 27 0.3× 27 1.5k
Gianfranco Floris United States 12 852 0.8× 71 0.2× 201 0.8× 130 1.0× 40 0.5× 13 931
Marta Serati Italy 19 516 0.5× 125 0.3× 246 1.0× 82 0.6× 73 0.9× 54 1.1k
Núria Cruz Spain 13 727 0.7× 132 0.4× 114 0.5× 142 1.1× 23 0.3× 21 900

Countries citing papers authored by C.L. Bowden

Since Specialization
Citations

This map shows the geographic impact of C.L. Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.L. Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.L. Bowden more than expected).

Fields of papers citing papers by C.L. Bowden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.L. Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.L. Bowden. The network helps show where C.L. Bowden may publish in the future.

Co-authorship network of co-authors of C.L. Bowden

This figure shows the co-authorship network connecting the top 25 collaborators of C.L. Bowden. A scholar is included among the top collaborators of C.L. Bowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.L. Bowden. C.L. Bowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pacchiarotti, Isabella, Norma Verdolini, Margherita Barbuti, et al.. (2019). Psychomotor symptoms in major depressive episode are related to bipolarity. A pooled analysis of the BRIDGE and BRIDGE-II-MIX cohorts. European Neuropsychopharmacology. 29. S353–S355. 1 indexed citations
2.
Angst, Jules, Alex Gamma, C.L. Bowden, et al.. (2013). Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity. European Archives of Psychiatry and Clinical Neuroscience. 263(8). 663–673. 55 indexed citations
3.
Young, Allan H., Jules Angst, Jean‐Michel Azorin, et al.. (2009). P.2.e.01l Characteristics of patients with bipolar disorder presenting a current major depressive episode: analysis in 8 countries. European Neuropsychopharmacology. 19. S454–S455. 1 indexed citations
4.
Nandar, Wint, et al.. (2007). Central visfatin causes orexigenic effects in chicks. Behavioural Brain Research. 186(2). 293–297. 46 indexed citations
5.
Peluso, Marco Aurélio Monteiro, J. P. Hatch, David C. Glahn, et al.. (2006). Trait impulsivity in patients with mood disorders. Journal of Affective Disorders. 100(1-3). 227–231. 166 indexed citations
6.
Caetano, Sheila C., Rene L. Olvera, Kristina Hunter, et al.. (2006). Association of psychosis with suicidality in pediatric bipolar I, II and bipolar NOS patients. Journal of Affective Disorders. 91(1). 33–37. 38 indexed citations
7.
Baker, Ross, C.L. Bowden, AK Kakkar, et al.. (2002). A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE).. Blood. 100(11). 13 indexed citations
8.
Calabrese, J.R., C.L. Bowden, R R Fieve, et al.. (2002). Lamotrigine or lithium in the maintenance treatment of bipolar I disorder. European Neuropsychopharmacology. 12. 217–217. 4 indexed citations
9.
Bowden, C.L., J.R. Calabrese, & Paul M. Thompson. (2002). Treatment of rapid cycling bipolar disorder. European Neuropsychopharmacology. 12. 95–96.
10.
Calabrese, Joseph D., C.L. Bowden, Susan L. McElroy, et al.. (1997). Lamictal Monotherapy in the treatment of bipolar disorder. European Neuropsychopharmacology. 1002(7). 3 indexed citations
11.
Bowden, C.L.. (1997). S.22.02 Long-term prophylactic treatment priorities in bipolar disorder. European Neuropsychopharmacology. 7. S123–S124. 2 indexed citations
12.
Bowden, C.L., P G Janicak, Paul J. Orsulak, et al.. (1996). Relation of serum valproate concentration to response in mania. American Journal of Psychiatry. 153(6). 765–770. 124 indexed citations
13.
Maas, James W., et al.. (1995). Clonidine Plus Haloperidol in the Treatment of Schizophrenia/Psychosis. Journal of Clinical Psychopharmacology. 15(5). 361–364. 14 indexed citations
14.
Rush, A. John, J. Mark Davis, J.R. Calabrese, et al.. (1995). Plasma GABA predicts response to divalproex in mania. Biological Psychiatry. 37(9). 601–601. 4 indexed citations
15.
Bowden, C.L.. (1994). Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania. JAMA. 271(12). 918–918. 675 indexed citations breakdown →
16.
Kocsis, James H., Jack Croughan, T. Butler, et al.. (1990). Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression. American Journal of Psychiatry. 147(5). 621–624. 36 indexed citations
17.
Javors, Martin A. & C.L. Bowden. (1987). The human platelet as a model for calcium metabolism in central nerve endings in the study of alcoholism.. PubMed. 7(5-6). 311–9. 3 indexed citations
18.
Bowden, C.L., et al.. (1980). Single-dose prediction of amitriptyline and nortriptyline requirement in unipolar depression. Current Therapeutic Research. 27(4). 635–642. 5 indexed citations
19.
Bowden, C.L., et al.. (1979). Toxic psychosis with cimetidine. American Journal of Psychiatry. 136(5). 725–726. 26 indexed citations
20.
Bowden, C.L.. (1978). Double-blind placebo-controlled trial of ketazolam in anxiety. Current Therapeutic Research. 24(2). 170–178. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026